{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:00:19Z","timestamp":1793692819727,"version":"4.5.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"50","license":[{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>Patients experiencing acute ischemic stroke or transient ischemic attack are commonly treated with clopidogrel and\/or aspirin (mono- and dual-antiplatelet therapy) to minimize the risk for recurrent stroke. Updated data from systematic studies can be used to guide practice. The present study aimed to compare findings from systematic reviews and meta-analyses addressing the efficacy and safety of clopidogrel or aspirin \u2013 alone or in combination \u2013 in patients experiencing acute ischemic stroke or transient ischemic attack.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The Cochrane Library, PubMed, Ovid, Scopus, EBSCO, and CINAHL databases were searched for relevant studies published from inception to 2020. Data from each study were extracted independently using a predefined data abstraction form. The Risk of Bias in Systematic Reviews tool and A Measurement Tool to Assess Systematic Reviews 2 were used to evaluate risk of bias and the quality of the included studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Seven studies, published between 2010 and 2020, were eligible for analysis. The included studies evaluated a wide range of outcomes, including recurrent stroke, myocardial infarction, recurrent ischemic stroke, vascular mortality and vascular events, bleeding events, all-cause mortality, functional disability, and quality of life. The risk of bias and methodological validity of the included studies ranged from low to high according to ROBIS and AMSTAR 2 parameters. Results revealed that clopidogrel plus aspirin was more effective than aspirin alone in reducing the risk for recurrent stroke (ischemic or hemorrhagic), with high-quality evidence. However, compared with aspirin, dual treatment increased major bleeding events (intracranial bleeding and extracranial bleeding), supported by high-quality evidence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>High-quality evidence suggested that clopidogrel plus aspirin was more efficient than monotherapy, although the risk for hemorrhagic stroke was relatively higher in combined therapy regimens lasting &gt;1\u200amonth.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000027804","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T13:11:58Z","timestamp":1639746718000},"page":"e27804","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":21,"title":["Efficacy and safety of clopidogrel and\/or aspirin for ischemic stroke\/transient ischemic attack"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4353-5059","authenticated-orcid":false,"given":"Youwen","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongtao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12,17]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/14737175.2021.1836963","article-title":"Acute ischemic stroke management: concepts and controversies. A narrative review","volume":"21","author":"Li","year":"2021","journal-title":"Expert Rev Neurother"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"05","DOI":"10.7326\/ACPJC-2003-139-1-005","article-title":"Review: anticoagulants are not more effective than antiplatelet agents in acute ischemic stroke","volume":"139","author":"Kronzon","year":"2003","journal-title":"ACP J Club"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/00207454.2019.1707822","article-title":"Effect of alteplase versus aspirin plus clopidogrel in acute minor stroke","volume":"130","author":"Lan","year":"2020","journal-title":"Int J Neurosci"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"e23620","DOI":"10.1097\/MD.0000000000023620","article-title":"Efficacy and safety of intravenous thrombolysis with alteplase for treating acute ischemic stroke at different time windows: a protocol for systematic review and meta-analysis","volume":"99","author":"Huang","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11883-015-0515-8","article-title":"Dual antiplatelet therapy in acute ischemic stroke","volume":"17","author":"Asdaghi","year":"2015","journal-title":"Curr Atheroscler Rep"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"e1067","DOI":"10.1212\/WNL.0000000000006168","article-title":"Dual antiplatelet therapy pretreatment in IV thrombolysis for acute ischemic stroke","volume":"91","author":"Tsivgoulis","year":"2018","journal-title":"Neurology"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/CNQ.0000000000000298","article-title":"Indications and evidence for dual antiplatelet therapy after acute ischemic stroke","volume":"43","author":"Ringler","year":"2020","journal-title":"Crit Care Nurs Q"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.7461\/jcen.2020.22.1.1","article-title":"Antiplatelet therapy within 24\u200ahours of tPA: lessons learned from patients requiring combined thrombectomy and stenting for acute ischemic stroke","volume":"22","author":"Brandel","year":"2020","journal-title":"J Cerebrovasc Endovasc Neurosurg"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"e13520","DOI":"10.1111\/ijcp.13520","article-title":"Dual antiplatelet treatment in acute ischemic stroke: translating guidelines into clinical practice","volume":"74","author":"Kollias","year":"2020","journal-title":"Int J Clin Pract"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"e006474","DOI":"10.1161\/CIRCOUTCOMES.119.006474","article-title":"Comparative effectiveness of dual antiplatelet therapy with aspirin and clopidogrel versus aspirin monotherapy in mild-to-moderate acute ischemic stroke according to the risk of recurrent stroke: an analysis of 15 000 patients from a nationwide, multicenter registry","volume":"13","author":"Lee","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.18632\/aging.202366","article-title":"Antiplatelet effect of ticagrelor with aspirin in acute minor stroke and transient ischemic attack stratified by CYP2C19 metabolizer status: subgroup analysis of the PRINCE trial","volume":"13","author":"Zhou","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"628077","DOI":"10.3389\/fneur.2021.628077","article-title":"Pre-treatment of single and double antiplatelet and anticoagulant with intravenous thrombolysis for older adults with acute ischemic stroke: the TTT-AIS experience","volume":"12","author":"Lin","year":"2021","journal-title":"Front Neurol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3892\/etm.2017.4459","article-title":"A systematic review and meta-analysis of published randomized controlled trials of combination of clopidogrel and aspirin in transient ischemic attack or minor stroke","volume":"14","author":"Zhou","year":"2017","journal-title":"Exp Ther Med"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1161\/STROKEAHA.118.023978","article-title":"Optimal duration of aspirin plus clopidogrel after ischemic stroke or transient ischemic attack","volume":"50","author":"Rahman","year":"2019","journal-title":"Stroke"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1607181","DOI":"10.1155\/2019\/1607181","article-title":"Benefits and risks of clopidogrel vs. aspirin monotherapy after recent ischemic stroke: a systematic review and meta-analysis","volume":"2019","author":"Paciaroni","year":"2019","journal-title":"Cardiovasc Ther"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11239-018-1786-z","article-title":"Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials","volume":"47","author":"Kheiri","year":"2019","journal-title":"J Thromb Thrombolysis"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"k5108","DOI":"10.1136\/bmj.k5108","article-title":"Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis","volume":"363","author":"Hao","year":"2018","journal-title":"BMJ"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"463","DOI":"10.7326\/0003-4819-159-7-201310010-00006","article-title":"Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis","volume":"159","author":"Lee","year":"2013","journal-title":"Ann Intern Med"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/STROKEAHA.111.637686","article-title":"Dual or mono antiplatelet therapy for patients with acute ischemic stroke or transient ischemic attack: systematic review and meta-analysis of randomized controlled trials","volume":"43","author":"Geeganage","year":"2012","journal-title":"Stroke"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027804","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:19:26Z","timestamp":1746335966000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027804"}},"subtitle":["An overview of systematic reviews and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,12,17]]},"references-count":19,"journal-issue":{"issue":"50","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000027804","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,17]]},"assertion":[{"value":"2021-04-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}